SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome

Leukemia and Lymphoma

Volumn 50, Issue 8, 2009, Pages 1318-1325

  Mansur, Marcela Braga ^a   Emerenciano, Mariana ^a   Brewer, Lilian ^a   Sant'Ana, Mariana ^a   Mendonça, Núbia ^b   Thuler, Luiz Claudio Santos ^a   Koifman, Sérgio ^c   Pombo De Oliveira, Maria S ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Sociedade de Oncologia da Bahia   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

HOX11L2; outcome; SIL TAL1; T cell acute lymphoblastic leukemia

Indexed keywords

ASPARAGINASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR TAL1; VINCRISTINE; ANTINEOPLASTIC AGENT; HOMEODOMAIN PROTEIN; ONCOPROTEIN; SIL TAL1 FUSION PROTEIN, HUMAN; SIL-TAL1 FUSION PROTEIN, HUMAN; TLX3 PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAZIL; CANCER PATIENT; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; FEMALE; FOLLOW UP; FUSION GENE; HUMAN; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; MATURATION; MOLECULAR DIAGNOSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIL TAL1 FUSION GENE; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; BLOOD; GENETICS; KAPLAN MEIER METHOD; MORTALITY; NEWBORN; PATHOLOGY;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; KAPLAN-MEIERS ESTIMATE; MALE; ONCOGENE PROTEINS, FUSION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 77649291948     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190903040014     Document Type: Article

References (32)

1. Aplan PD, Lombardi DP, Reaman GH, et al. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 1992;79:1327-1333.
2. Bash RO, Crist WM, Shuster JJ, et al. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood 1993;81:2110-2117. (Pubitemid 23106726)
3. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-1786.
4. Hrusak O, Porwit-MacDonald A. Antigen expression patterns reflecting genotype of acute leukemias. Leukemia 2002;16:1233-1258.
5. Niehues T, Kapaun P, Harms DO, et al. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Leukemia 1999;13:614-617. (Pubitemid 29195292)
6. Berger R, Dastugue N, Busson M, et al. t (5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia 2003;17:1851-1857. (Pubitemid 37185262)
7. Delabesse E, Bernard M, Landman-Parker J, et al. Simultaneous SIL-TAL1 RT-PCR detection of all tal (d) deletions and identification of novel tal (d) variants. Br J Haematol 1997;99:901-907. (Pubitemid 28047157)
8. Heerema NA, Sather HN, Sensel MG, et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. J Clin Oncol 1998;16:1270-1278. (Pubitemid 28175739)
9. Schneider NR, Carroll AJ, Shuster JJ, et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood 2000;96:2543-2549.
10. Bernard OA, Busson-LeConiat M, Ballerini P, et al. A new recurrent and specific cryptic translocation, t (5;14) (q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001;15:1495-1504. (Pubitemid 32994666)
11. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002;1:75-87. (Pubitemid 41039178)
12. Cave H, Suciu S, Preudhomme C, et al. Clinical significance of HOX11L2 expression linked to t (5;14) (q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004;103:442-450. (Pubitemid 38140071)
13. Brandalise S, Pombo-de-Oliveira MS, Pinheiro V R P, et al. Influence of race and nutritional status on the long-term event free survival in childhood acute lymphoblastic leukemia (ALL): a 14-year follow-up with a reduced BFM-based treatment protocol (GBTLI ALL-93) [abstract]. Blood 2008;112:11.
14. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000;14:2205-2222. (Pubitemid 32042262)
15. Parra FC, Amado RC, Lambertucci JR, et al. Color and genomic ancestry in brazilians. Proc Natl Ac Sci 2003;100:177-182. (Pubitemid 36078048)
16. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24. (Pubitemid 26019992)
17. Jaffe ES, Harris NL, Stein H, et al. World health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2004.
18. Emerenciano M, Agudelo Arias DP, Coser VM, et al. Molecular cytogenetic findings of acute leukemia included in the Brazilian Collaborative Study Group of Infant acute leukemia. Pediatr Blood Cancer 2006;47:549-554. (Pubitemid 44360054)
19. van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901-1928.
20. Garand R, Voisin S, Papin S, et al. Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucemies. Leukemia 1993;7:161-167. (Pubitemid 23079220)
21. van GM, Meijerink JP, van Wering ER, et al. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia 2008;22:124-131.
22. Curry JD, Smith MT. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR. Leuk Res 2003;27:575-582. (Pubitemid 36398092)
23. O'Neil J, Shank J, Cusson N, et al. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 2004;5:587-596. (Pubitemid 38748920)
24. Chiaretti S, Li X, Gentleman R, et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 2004;103:2771-2778. (Pubitemid 38393036)
25. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-1548.
26. Pullen J, Shuster JJ, Link M, et al. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999;13:1696-1707. (Pubitemid 29535250)
27. Breit S, Stanulla M, Flohr T, et al. Activating NOTCH1 mutations predict favorable early treatment response and longterm outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 2006;108:1151-1157. (Pubitemid 44232009)
28. Ballerini P, Landman-Parker J, Cayuela JM, et al. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica 2008;93:1658-1665.
29. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 2002;100:1957-1964. (Pubitemid 35001223)
30. Viana MB, Fernandes RA, de Oliveira BM, et al. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica 2001;86:113-120. (Pubitemid 32216082)
31. Ludwig WD, Harbott J, Bartram CR, et al. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86. Recent Results Cancer Res 1993;131:269-282.
32. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471-2475. (Pubitemid 38669191)